Published in Biochem J on July 01, 1983
Insulin and glucagon regulate the activation of two distinct membrane-bound cyclic AMP phosphodiesterases in hepatocytes. Biochem J (1983) 1.82
The insulin- and glucagon-stimulated 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Purification, characterization and inhibitor sensitivity. Biochem J (1987) 1.05
Insulin activates the plasma-membrane and dense-vesicle cyclic AMP phosphodiesterase in hepatocytes by distinct routes. Biochem J (1983) 0.94
Heterogeneity of cyclic nucleotide phosphodiesterases in liver endoplasmic reticulum. Biochem J (1983) 0.88
Purification of cyclic 3',5'-nucleotide phosphodiesterase inhibitory protein by affinity chromatography on activator protein coupled to Sepharose. Biochemistry (1978) 2.89
Molecular basis of insulin action. Annu Rev Biochem (1977) 2.16
A peripheral and an intrinsic enzyme constitute the cyclic AMP phosphodiesterase activity of rat liver plasma membranes. Biochem J (1980) 2.14
Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues. J Biol Chem (1982) 2.12
Structures and activities of protease inhibitors of microbial origin. Methods Enzymol (1976) 2.03
Cyclic nucleotide phosphodiesterases. Adv Cyclic Nucleotide Res (1977) 1.75
Stimulation of a low Km phosphodiesterase from liver by insulin and glucagon. J Biol Chem (1978) 1.49
Cyclic nucleotide phosphodiesterases. Adv Cyclic Nucleotide Res (1973) 1.42
Purification and properties of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase. J Biol Chem (1980) 1.31
Purification and characterization of phosphodiesterase activator from kidney. A lysosomal protease. J Biol Chem (1979) 0.94
Theoretical analysis of the consequences of cyclic nucleotide phosphodiesterase negative co-operativity. Amplification and positive co-operativity of cyclic AMP accumulation. Biochem J (1980) 0.94
The insulin-stimulated cyclic AMP phosphodiesterase binds to a single class of protein sites on the liver plasma membrane. Biochem J (1981) 0.91
Heterogeneity of cyclic nucleotide phosphodiesterases in liver endoplasmic reticulum. Biochem J (1983) 0.88
Submitochondrial localization and asymmetric disposition of two peripheral cyclic nucleotide phosphodiesterases. Biochem J (1982) 0.88
Proteolytic solubilization and modification of hormone-sensitive cyclic nucleotide phosphodiesterase. J Biol Chem (1980) 0.87
Reconsideration of the multiple cyclic nucleotide phosphodiesterases in bovine heart. Biochem Biophys Res Commun (1978) 0.81
Evidence for the presence of a serine proteinase(s) associated with the microsomal membranes of rat liver. J Biochem (1978) 0.80
Effects of dithiothreitol on insulin-sensitive phosphodiesterase in rat fat cells. Biochim Biophys Acta (1982) 0.80
Separation of three cyclic-nucleotide-phosphodiesterases from bovine aorta. Biochem Biophys Res Commun (1978) 0.79
Use of MEDLINE by physicians for clinical problem solving. JAMA (1993) 6.51
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med (2012) 4.21
Appendicitis at the millennium. Radiology (2000) 3.70
Normal p21N-ras couples bombesin and other growth factor receptors to inositol phosphate production. Nature (1986) 3.41
mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J (2001) 2.86
Radiology reports: examining radiologist and clinician preferences regarding style and content. AJR Am J Roentgenol (2001) 2.63
Ethical decision making and patient autonomy: a comparison of physicians and patients in Japan and the United States. Chest (2000) 2.44
Uterine arteriovenous malformations: gray-scale and Doppler US features with MR imaging correlation. Radiology (1998) 2.42
Cholesterol is excluded from the phospholipid annulus surrounding an active calcium transport protein. Nature (1975) 2.30
Activation of two signal-transduction systems in hepatocytes by glucagon. Nature (1986) 2.21
Analyzing gene-frequency data when the effective population size is finite. Genetics (1980) 2.15
A peripheral and an intrinsic enzyme constitute the cyclic AMP phosphodiesterase activity of rat liver plasma membranes. Biochem J (1980) 2.14
The glucagon receptor of rat liver plasma membrane can couple to adenylate cyclase without activating it. Biochim Biophys Acta (1976) 2.07
Annular lipids determine the ATPase activity of a calcium transport protein complexed with dipalmitoyllecithin. Biochemistry (1976) 2.06
Is an early calcium flux necessary to stimulate lymphocytes? Nature (1977) 2.03
A subset of olfactory neurons that selectively express cGMP-stimulated phosphodiesterase (PDE2) and guanylyl cyclase-D define a unique olfactory signal transduction pathway. Proc Natl Acad Sci U S A (1997) 1.95
Abolition of the expression of inhibitory guanine nucleotide regulatory protein Gi activity in diabetes. Nature (1987) 1.93
Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis. Br J Pharmacol (2009) 1.89
The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579. EMBO J (1999) 1.85
Insulin and glucagon regulate the activation of two distinct membrane-bound cyclic AMP phosphodiesterases in hepatocytes. Biochem J (1983) 1.82
The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform. J Biol Chem (1999) 1.77
Bridging language and cultural barriers between physicians and patients. Public Health Rep (1997) 1.71
Biological applications of fullerenes. Bioorg Med Chem (1996) 1.70
ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4D cAMP-specific phosphodiesterases. The involvement of COOH-terminal docking sites and NH2-terminal UCR regions. J Biol Chem (2000) 1.68
Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol (2000) 1.64
Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax (2005) 1.64
Selection for ethanol tolerance in two populations of Drosophila melanogaster segregating alcohol dehydrogenase allozymes. Aust J Biol Sci (1979) 1.59
Purification and properties of the insulin-stimulated cyclic AMP phosphodiesterase from rat liver plasma membranes. Biochem J (1981) 1.58
Challenge of hepatocytes by glucagon triggers a rapid modulation of adenylate cyclase activity in isolated membranes. Biochem J (1983) 1.53
Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene. Biochem J (1997) 1.51
Changes in the form of Arrhenius plots of the activity of glucagon-stimulated adenylate cyclase and other hamster liver plasma-membrane enzymes occurring on hibernation. Biochem J (1978) 1.51
The increase in bilayer fluidity of rat liver plasma membranes achieved by the local anesthetic benzyl alcohol affects the activity of intrinsic membrane enzymes. J Biol Chem (1980) 1.49
The nature of the electrophoretically separable multiple forms of rat liver monoamine oxidase. Biochem J (1973) 1.47
Exchange of partners in glucagon receptor-adenylate cyclase complexes. Physical evidence for the independent, mobile receptor model. Biochim Biophys Acta (1977) 1.46
cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular model. Biochem J (1998) 1.46
The insulin receptor tyrosyl kinase phosphorylates holomeric forms of the guanine nucleotide regulatory proteins Gi and Go. FEBS Lett (1987) 1.46
Diminished bacterial defences with intralipid. Lancet (1980) 1.43
Postvaccination sarcomas in cats. J Am Vet Med Assoc (1993) 1.42
A simple method for sequencing small DNAs by introducing precise overlapping ends into restriction digestion fragments. Nucleic Acids Res (1998) 1.40
Predicting AIDS deaths and prevalence in Australia. Med J Aust (1992) 1.39
Guanine-nucleotide-binding proteins expressed in rat white adipose tissue. Identification of both mRNAs and proteins corresponding to Gi1, Gi2 and Gi3. Biochem J (1989) 1.37
Mutant but not normal p21 ras elevates inositol phospholipid breakdown in two different cell systems. Oncogene (1988) 1.37
Hormonal regulation of Gi2 alpha-subunit phosphorylation in intact hepatocytes. Biochem J (1990) 1.37
A kinetic evaluation of monoamine oxidase activity in rat liver mitochondrial outer membranes. Biochem J (1974) 1.35
Insulin inhibits the cholera-toxin-catalysed ribosylation of a Mr-25000 protein in rat liver plasma membranes. Biochem J (1985) 1.35
Analysis of Australian Crohn's disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16. Ann Hum Genet (1998) 1.34
The lipid environment of the glucagon receptor regulates adenylate cyclase activity. Biochim Biophys Acta (1976) 1.34
The partition matrix: exploring variable phylogenetic signals along nucleotide sequence alignments. Mol Biol Evol (1997) 1.34
Insulin trigger, cyclic AMP-dependent activation and phosphorylation of a plasma membrane cyclic AMP phosphodiesterase. Nature (1980) 1.34
Insulin exerts actions through a distinct species of guanine nucleotide regulatory protein: inhibition of adenylate cyclase. Biochem J (1983) 1.32
Phosphodiesterase isoforms in the pulmonary arterial circulation of the rat: changes in pulmonary hypertension. J Pharmacol Exp Ther (1997) 1.29
The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function. Mol Psychiatry (2010) 1.28
Manifestations of Crohn disease at US. Radiographics (1996) 1.27
The activity of glucagon-stimulated adenylate cyclase from rat liver plasma membranes is modulated by the fluidity of its lipid environment. Biochem J (1978) 1.27
Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases. Br J Pharmacol (2000) 1.27
Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics. Proc Natl Acad Sci U S A (1998) 1.25
Acute effects of inhaled salbutamol on the metabolic rate of normal subjects. Thorax (1993) 1.25
Diabetes-induced alterations in the expression, functioning and phosphorylation state of the inhibitory guanine nucleotide regulatory protein Gi-2 in hepatocytes. Biochem J (1990) 1.25
Intrathoracic manifestations of amyloid disease. Radiology (1976) 1.24
Characterization of the phosphorylated form of the insulin-stimulated cyclic AMP phosphodiesterase from rat liver plasma membranes. Biochem J (1981) 1.23
Forskolin and ethanol both perturb the structure of liver plasma membranes and activate adenylate cyclase activity. Biochem Pharmacol (1983) 1.23
Platelet activating factor and U44069 stimulate a GTPase activity in human platelets which is distinct from the guanine nucleotide regulatory proteins, Ns and Ni. Biochem J (1986) 1.21
Cholera toxin mediated activation of adenylate cyclase in intact rat hepatocytes. FEBS Lett (1979) 1.19
Association with the SRC family tyrosyl kinase LYN triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B. Consequences for rolipram inhibition. J Biol Chem (1999) 1.19
Synthetic and structural studies on [Fe2(SR)2(CN)x(CO)6-x](x-) as active site models for Fe-only hydrogenases. J Am Chem Soc (2001) 1.18
The phorbol ester, TPA inhibits glucagon-stimulated adenylate cyclase activity. FEBS Lett (1984) 1.18
Ultrasound for the visualization and quantification of tumor microcirculation. Cancer Metastasis Rev (2000) 1.18
UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions. J Biol Chem (2000) 1.18
Leiomyosarcoma of the portal vein. AJR Am J Roentgenol (1987) 1.17
Identification and characterization of the type-IVA cyclic AMP-specific phosphodiesterase RD1 as a membrane-bound protein expressed in cerebellum. Biochem J (1995) 1.17
Log-linear models for linked loci. Biometrics (1986) 1.17
Insulin, glucagon and the receptor-mediated control of cyclic AMP concentrations in liver. Twenty-second Colworth medal lecture. Biochem Soc Trans (1986) 1.17
Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics (1998) 1.16
Membrane localization of cyclic nucleotide phosphodiesterase 3 (PDE3). Two N-terminal domains are required for the efficient targeting to, and association of, PDE3 with endoplasmic reticulum. J Biol Chem (2000) 1.16
Genetic counseling in rare syndromes: a resampling method for determining an approximate confidence interval for gene location with linkage data from a single pedigree. Am J Hum Genet (1990) 1.15
Guanosine 5'-triphosphate and guanosine 5'-[beta gamma-imido]triphosphate effect a collision coupling mechanism between the glucagon receptor and catalytic unit of adenylate cyclase. Biochem J (1980) 1.14
Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family. Biochem J (1995) 1.14
Disruption of the cyclic AMP phosphodiesterase-4 (PDE4)-HSP20 complex attenuates the β-agonist induced hypertrophic response in cardiac myocytes. J Mol Cell Cardiol (2011) 1.14
Thrombin, unlike vasopressin, appears to stimulate two distinct guanine nucleotide regulatory proteins in human platelets. Biochem J (1986) 1.13
Islet-activating protein blocks glucagon desensitization in intact hepatocytes. Biochem J (1984) 1.13
How important is DNA replication for mutagenesis? Mol Biol Evol (2000) 1.13
Immunoprecipitation and opsonic cross-reaction between type-14 pneumococcus and group-B streptococcus type III. Lancet (1979) 1.12
Atypical hepatic hemangioma: a suggestive sonographic morphology. Radiology (1993) 1.12
Synthetic approaches to a variety of covalently linked porphyrin--fullerene hybrids. J Org Chem (2001) 1.12
Treatment of intact hepatocytes with either the phorbol ester TPA or glucagon elicits the phosphorylation and functional inactivation of the inhibitory guanine nucleotide regulatory protein Gi. FEBS Lett (1989) 1.12
Guanine nucleotides can activate the insulin-stimulated phosphodiesterase in liver plasma membranes. FEBS Lett (1983) 1.11
Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form. Biochem Pharmacol (1989) 1.11
An assessment of the ability of insulin-stimulated cyclic AMP phosphodiesterase to decrease hepatocyte intracellular cyclic AMP concentrations. Biochem J (1984) 1.10
In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions. J Immunol (1999) 1.10
Identification of a surface on the beta-propeller protein RACK1 that interacts with the cAMP-specific phosphodiesterase PDE4D5. Cell Signal (2001) 1.09
Respiratory effects associated with indoor nitrogen dioxide exposure in children. Int J Epidemiol (1997) 1.09
The chemistry of the Euphorbiaceae. A new diterpene from Croton californicus. J Am Chem Soc (1976) 1.08
X-ray crystal structure of an anti-Buckminsterfullerene antibody fab fragment: biomolecular recognition of C(60). Proc Natl Acad Sci U S A (2000) 1.08
Membrane phosphorylation: a crucial role in the action of insulin, EGF, and pp60src? Biosci Rep (1981) 1.08